Literature DB >> 2855793

Retroviral-mediated gene transfer. Applications in neurobiology.

M M Lo1, M K Conrad, C Mamalaki, M J Kadan.   

Abstract

There are now many examples of the successful expression of genes transduced by retroviruses in studies from outside the field of neuroscience. Retroviruses will undoubtedly also prove to be effective tools for neuro-scientists interested in expressing cloned neurotransmitter and receptor genes. There are also other less obvious applications of retroviruses, such as their insertional mutagenic effects, which may be useful in studies of the genetic factors and biochemical mechanisms involved in, for example, neurotoxicity. Strong cellular promoters have been identified by retroviral infection and subsequent rescue of the flanking genomic DNA. Retroviruses can be employed again to reintroduce these regulatory sequences back into cells. In this way the complexities of gene expression in the many subpopulations of neurons may be unraveled. Retroviruses can also serve as very useful genetic markers in studies of development and lineage relationships. Retroviruses may be used to efficiently transfer oncogenes into neuronal cells to create new cell lines. This application exploits one of the natural traits of retroviruses--oncogenesis--which led to their original discovery. Finally, there are neurotropic retroviruses that could serve as important vectors for delivering genes into neurons. Studying these retroviruses may lead to an understanding of how they cause neuropathologic changes in the CNS.

Entities:  

Mesh:

Year:  1988        PMID: 2855793     DOI: 10.1007/bf02935344

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  102 in total

1.  Gene isolation by retroviral tagging.

Authors:  S P Goff
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

2.  Expression of an exogenous growth hormone gene by transplantable human epidermal cells.

Authors:  J R Morgan; Y Barrandon; H Green; R C Mulligan
Journal:  Science       Date:  1987-09-18       Impact factor: 47.728

3.  Expression of genes introduced into cells by retroviral infection is more efficient than that of genes introduced into cells by DNA transfection.

Authors:  L H Hwang; E Gilboa
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

4.  Introduction of a selectable gene into primitive stem cells capable of long-term reconstitution of the hemopoietic system of W/Wv mice.

Authors:  J E Dick; M C Magli; D Huszar; R A Phillips; A Bernstein
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

5.  Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase.

Authors:  K Chiba; A Trevor; N Castagnoli
Journal:  Biochem Biophys Res Commun       Date:  1984-04-30       Impact factor: 3.575

6.  Insertion of retrovirus into the first intron of alpha 1(I) collagen gene to embryonic lethal mutation in mice.

Authors:  K Harbers; M Kuehn; H Delius; R Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

7.  Association of the lethal yellow (Ay) coat color mutation with an ecotropic murine leukemia virus genome.

Authors:  N G Copeland; N A Jenkins; B K Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

8.  Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome.

Authors:  R Nusse; H E Varmus
Journal:  Cell       Date:  1982-11       Impact factor: 41.582

9.  Inhibition of dopamine uptake by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, a cause of parkinsonism.

Authors:  T Denton; B D Howard
Journal:  Biochem Biophys Res Commun       Date:  1984-03-30       Impact factor: 3.575

10.  Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells.

Authors:  S F Yu; T von Rüden; P W Kantoff; C Garber; M Seiberg; U Rüther; W F Anderson; E F Wagner; E Gilboa
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.